Do Your Patients Know About Double Dosing?
Do Your Patients Know About Double Dosing?The problem affects thousands of people every year.
Safety Communication: Biotin May Interfere with Lab Test Results
Safety Communication: Biotin May Interfere with Lab Test ResultsBiotin, AKA vitamin B7, appears to significantly throw off the results of certain lab tests.
Promoting Drug Safety During Breastfeeding
Promoting Drug Safety During BreastfeedingPharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
Prevent polypharmacy problemsPolypharmacy presents real problems—especially for older adults.
The use of microsponges in dandruff shampoosMicrosponges are very small sponges that can be loaded with substances for delivery to the skin. The most interesting use of microsponges in OTC (over-the-counter) drug dermatologics is in dandruff shampoos.
Singulair as OTC product voted down by FDAAn FDA advisory panel recommended against Merck’s attempt to sell its prescription drug, montelukast sodium (Singulair), as an over-the-counter product for allergy relief in adults only.
FDA approves OTC NexiumFDA has approved non-prescription esomeprazole 20mg (Nexium 24HR, Pfizer).
PODCAST: A plethora of aesthetic productsCosmetic concerns are important to many of our patients. Among the difficulties faced by consumers is the blitz of advertising of new and presumably revolutionary products that can rejuvenate and preserve the youthful appearance of the skin. Many products make what sound like medical claims about the efficacy of these agents. Norman Levine, M.D., asked Zoe Draelos, M.D., the foremost authority on this subject, to discuss these issues with us.
Treating kids' nasal congestionParents find both pediatrician-recommended and nonrecommended treatments for kids' nasal congestion effective.
Parents ignore advice about OTC medicines for kidsA new nationwide poll finds that parents are still giving over-the-counter (OTC) cough and cold medicines to their children aged younger than 4 years, a practice that is contrary to advisories from the US Food and Drug Administration.